{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:10:56Z","timestamp":1773835856020,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","funder":[{"DOI":"10.13039\/100006380","name":"Rehabilitation Research and Development Service","doi-asserted-by":"publisher","award":["N3197"],"award-info":[{"award-number":["N3197"]}],"id":[{"id":"10.13039\/100006380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006380","name":"Rehabilitation Research and Development Service","doi-asserted-by":"publisher","award":["N3197"],"award-info":[{"award-number":["N3197"]}],"id":[{"id":"10.13039\/100006380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Military Service Members, Veterans, and other patient populations who experience traumatic brain injury (TBI) may have increased risk of early neurodegenerative diseases relative to those without TBI history. Some evidence suggests that exposure to psychotropic medications may play a role in this association. The Long-term Impact of Military-relevant Brain Injury Consortium\u2014Chronic Effects of Neurotrauma Consortium (LIMBIC-CENC) prospective longitudinal study provides an ideal setting to examine the effects of psychotropic medication exposure on long-term neurological health of those with and without mild TBI history. In this study, we sought to develop and pilot test a self-report electronic survey instrument to measure participants\u2019 psychotropic medication histories for use across LIMBIC-CENC study sites.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>We developed a new survey instrument measuring psychotropic medication history and fielded it among Service Members and Veterans enrolled in a single site of the LIMBIC-CENC study to evaluate response rates and patterns, and to compare survey responses to prescription data extracted from participants\u2019 Veterans Affair (VA) records. Descriptive statistics estimated survey respondents\u2019 lifetime psychotropic medication exposures by their TBI history and other demographic and clinical characteristics of interest. We also compared survey responses to participants\u2019 VA outpatient prescription records to estimate sensitivity and negative predictive values (NPVs) for participants\u2019 self-reported medication exposures relative to this single prescription data source.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 310 Veterans enrolled at the study site, 249 completed the survey (response rate\u2009=\u200980%), of whom 248 also had VA health records and were included in the analysis. Most (69%) had a history of mild TBI. Over three-fourths of survey respondents (78%) reported ever having used prescription opioids, 26% reported benzodiazepines, 50% reported muscle relaxants, 42% reported antidepressants, 13% reported non-benzodiazepine sedative-hypnotics, 15% reported stimulants, 7% reported mood stabilizers, and 6% reported antipsychotics. Veterans with, versus without, a history of mild TBI were more likely to self-report psychotropic medication history as well as have confirmed receipt of VA prescriptions for each medication class. Using VA records as a criterion standard, the sensitivity of the survey for detecting VA prescriptions ranged from 19% to 84%, while the NPVs ranged from 64% to 97%. Sensitivity and NPVs were similar for participants with, versus without, mild TBI history.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Service Members and Veterans may receive psychotropic medications from multiple sources over their lifetimes. Valid methods to examine and quantify these exposures among those with a history of TBI are important, particularly as we evaluate causes of neurodegenerative disorders in this population over time. The measurement of Veterans\u2019 lifetime psychotropic medication exposures using a self-report survey, in combination with health care records, holds promise as a valid approach, but further testing and refinement are needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usae120","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T16:35:58Z","timestamp":1724085358000},"page":"323-331","source":"Crossref","is-referenced-by-count":3,"title":["Lifetime Psychotropic Medication Use Among Service Members and Veterans With and Without History of Mild Traumatic Brain Injury: A Pilot Study"],"prefix":"10.1093","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9261-7742","authenticated-orcid":false,"given":"Kathleen F","family":"Carlson","sequence":"first","affiliation":[{"name":"VA Health Services Research & Development Service Center of Innovation, Center to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D 66) , Portland, OR 97239, USA"},{"name":"VA Rehabilitation Research & Development Service, National Center for Rehabilitative Auditory Research, VA Portland Health Care System (P5-NCRAR) , Portland, OR 97239, USA"},{"name":"Oregon Health and Science University\u2014Portland State University School of Public Health (Epidemiology) , Portland, OR 97239, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6945-3054","authenticated-orcid":false,"given":"Tess A","family":"Gilbert","sequence":"additional","affiliation":[{"name":"VA Health Services Research & Development Service Center of Innovation, Center to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D 66) , Portland, OR 97239, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Joyce","sequence":"additional","affiliation":[{"name":"VA Health Services Research & Development Service Center of Innovation, Center to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D 66) , Portland, OR 97239, USA"},{"name":"Oregon Health and Science University\u2014Portland State University School of Public Health (Epidemiology) , Portland, OR 97239, USA"},{"name":"School of Medicine, Oregon Health and Science University , Portland, OR 97239, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Edmunds","sequence":"additional","affiliation":[{"name":"VA Health Services Research & Development Service Center of Innovation, Center to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D 66) , Portland, OR 97239, USA"},{"name":"VA Rehabilitation Research & Development Service, National Center for Rehabilitative Auditory Research, VA Portland Health Care System (P5-NCRAR) , Portland, OR 97239, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Govier","sequence":"additional","affiliation":[{"name":"VA Health Services Research & Development Service Center of Innovation, Center to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D 66) , Portland, OR 97239, USA"},{"name":"Oregon Health and Science University\u2014Portland State University School of Public Health (Epidemiology) , Portland, OR 97239, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"2024082004113331400_R1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1212\/WNL.55.8.1158","article-title":"Documented head injury in early adulthood and risk of Alzheimer\u2019s disease and other dementias","volume":"55(8)","author":"Plassman","year":"2000","journal-title":"Neurology"},{"key":"2024082004113331400_R2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/WNL.0000000000000616","article-title":"Traumatic brain injury and risk of dementia in older Veterans","volume":"83(4)","author":"Barnes","year":"2014","journal-title":"Neurology"},{"issue":"9","key":"2024082004113331400_R3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jamaneurol.2018.0815","article-title":"Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military Veterans","volume":"75","author":"Barnes","year":"2018","journal-title":"JAMA Neurol"},{"issue":"1","key":"2024082004113331400_R4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169650","article-title":"Head injury as a risk factor for dementia and Alzheimer\u2019s disease: a systematic review and meta-analysis of 32 observational studies","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"issue":"30","key":"2024082004113331400_R5","doi-asserted-by":"publisher","first-page":"S242","DOI":"10.1016\/j.jalz.2014.04.003","article-title":"Military-related traumatic brain injury and neurodegeneration","volume":"10","author":"McKee","year":"2014","journal-title":"Alzheimers Dementia"},{"key":"2024082004113331400_R6","article-title":"Traumatic Brain Injury Center of Excellence","author":"Defense Health Agency"},{"key":"2024082004113331400_R7","article-title":"What\u2019s in a name: Polytrauma and how VA cares for severely injured vets","volume-title":"VAantage Point","author":"Beck","year":"2011"},{"issue":"9","key":"2024082004113331400_R8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1682\/JRRD.2013.01.0006","article-title":"Traumatic brain injury, posttraumatic stress disorder, and pain diagnoses in OIF\/OEF\/OND Veterans","volume":"50","author":"Cifu","year":"2013","journal-title":"J Rehabil Res Dev"},{"key":"2024082004113331400_R9","article-title":"Chronic Effects of Neurotrauma Consortium (LIMBIC-CENC)","volume-title":"What is LIMBIC-CENC?","author":"Long-term Impact of Military-Relevant Brain Injury Consortium","year":"2024"},{"issue":"12","key":"2024082004113331400_R10","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1080\/02699052.2016.1219061","article-title":"The Chronic Effects of Neurotrauma Consortium (CENC) Multi-Center Observational Study: description of study and characteristics of early participants","volume":"30","author":"Walker","year":"2016","journal-title":"Brain Injury"},{"issue":"8","key":"2024082004113331400_R11","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/jgs.13562","article-title":"Prescription opioids and risk of dementia or cognitive decline: a prospective cohort study","volume":"63","author":"Dublin","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"2024082004113331400_R12","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1111\/jgs.18030","article-title":"Prescription opioids and longitudinal changes in cognitive function in older adults: a population-based observational study","volume":"70","author":"Warner","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"2024082004113331400_R13","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.jamda.2023.06.035","article-title":"Long-term opioid use and dementia risk in patients with chronic pain","volume":"24","author":"Sun","year":"2023","journal-title":"J Am Med Directors Assoc"},{"issue":"10","key":"2024082004113331400_R14","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/phar.2170","article-title":"Association between development of dementia and use of benzodiazepines: a systematic review and meta-analysis","volume":"38","author":"Lucchetta","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"5","key":"2024082004113331400_R15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"psychotropic medication, and dementia: a population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimers Dementia"},{"key":"2024082004113331400_R16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/acps.13380","article-title":"The risk of dementia in patients using psychotropic drugs: antidepressants, mood stabilizers or antipsychotics","volume":"145(1)","author":"Tournier","year":"2022","journal-title":"Acta Psychiatr Scand"},{"issue":"11","key":"2024082004113331400_R17","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jagp.2019.05.019","article-title":"Exposure to antidepressant medication and the risk of incident dementia","volume":"27","author":"Kodesh","year":"2019","journal-title":"Am J Geriatric Psychiatry"},{"issue":"2","key":"2024082004113331400_R18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2174\/2589977514666220301102717","article-title":"Antipsychotic medication risk of dementia and death: a propensity matched cohort study","volume":"14","author":"Lowe","year":"2022","journal-title":"Curr Drug Res Rev"},{"issue":"5","key":"2024082004113331400_R19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/j.pain.0000000000000837","article-title":"Impact of the opioid safety initiative on opioid-related prescribing in Veterans","volume":"158","author":"Lin","year":"2017","journal-title":"Pain"},{"issue":"5","key":"2024082004113331400_R20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamainternmed.2017.0147","article-title":"Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs","volume":"177","author":"Gellad","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"8","key":"2024082004113331400_R21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jpain.2018.03.005","article-title":"Traumatic brain injury and receipt of prescription opioid therapy for chronic pain in Iraq and Afghanistan Veterans: do clinical practice guidelines matter?","volume":"19","author":"Seal","year":"2018","journal-title":"J Pain"},{"issue":"5","key":"2024082004113331400_R22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/HTR.0000000000000712","article-title":"Opioid and sedative-hypnotic prescriptions among Post-9\/11 Veteran VA users nationwide with traumatic brain injury, 2012-2020","volume":"36","author":"Holmer","year":"2021","journal-title":"J Head Trauma Rehabil"},{"issue":"3-4","key":"2024082004113331400_R23","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1093\/milmed\/usx050","article-title":"A comparison of Veterans with post-traumatic stress disorder, with mild traumatic brain injury and with both disorders: understanding multimorbidity","volume":"183","author":"Kulas","year":"2018","journal-title":"Mil Med"},{"issue":"Suppl 3","key":"2024082004113331400_R24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s11606-022-07592-4","article-title":"Long-term psychoactive medications, polypharmacy, and risk of suicide and unintended overdose death among midlife and older women Veterans","volume":"37","author":"Gibson","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"2","key":"2024082004113331400_R25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1176\/appi.ps.201000531","article-title":"Pharmacotherapy regimens among patients with posttraumatic stress disorder and mild traumatic brain injury","volume":"63","author":"Morgan","year":"2012","journal-title":"Psychiatric Serv"},{"key":"2024082004113331400_R26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2021.108537","article-title":"Using ICD-10-CM codes to detect illicit substance use: a comparison with retrospective self-report","volume":"221","author":"Rowe","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"2024082004113331400_R27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cct.2016.07.013","article-title":"Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use\/misuse (TAPS) tool","volume":"50","author":"Wu","year":"2016","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"2024082004113331400_R28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-019-0339-x","article-title":"Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study","volume":"17","author":"Martens","year":"2020","journal-title":"Harm Reduct J"},{"key":"2024082004113331400_R29","article-title":"Guide to CENC Lifetime Concussion and TBI Mapping Interview Toolkit for External Use","author":"Long-term Impact of Military-Relevant Brain Injury Consortium \u2013 Chronic Effects of Neurotrauma Consortium (LIMBIC-CENC)"},{"issue":"7","key":"2024082004113331400_R30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/neu.2014.3433","article-title":"Structured interview for mild traumatic brain injury after military blast: inter-rater agreement and development of a diagnostic algorithm","volume":"32","author":"Walker","year":"2015","journal-title":"J Neurotrauma"},{"key":"2024082004113331400_R31","article-title":"VA\/DoD Clinical Practice Guideline","volume-title":"Management and Rehabilitation of Post-acute Mild Traumatic Brain Injury","author":"U.S. Department of Veterans Affairs and Department of Defense","year":"2021"},{"key":"2024082004113331400_R32","article-title":"International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9CM)","author":"U.S. Centers for Disease Control and Prevention, National Center for Health Statistics"},{"key":"2024082004113331400_R33","article-title":"International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM)","author":"U.S. Centers for Disease Control and Prevention, National Center for Health Statistics"},{"key":"2024082004113331400_R34","article-title":"2017 ICD-10-CM and GEMS","author":"U.S. Centers for Medicaid & Medicare Services","year":"2016"},{"key":"2024082004113331400_R35","article-title":"VA Formulary Advisor","author":"U.S. Department of Veterans Affairs, Pharmacy Benefits Management Services","year":"2023"},{"key":"2024082004113331400_R36","article-title":"Technical Assistance Guide: History of Prescription Drug Monitoring Programs","author":"Brandeis University, Heller School for Social Policy and Management, Prescription Drug Monitoring Program Training and Technical Assistance Center","year":"2018"},{"key":"2024082004113331400_R37","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1111\/1475-6773.13025","article-title":"Linkage of VA and state prescription drug monitoring program data to examine concurrent opioid and sedative-hypnotic prescriptions among Veterans","volume":"53(Suppl 3)","author":"Carlson","year":"2018","journal-title":"Health Serv Res"},{"issue":"8","key":"2024082004113331400_R38","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1089\/neu.2019.6580","article-title":"Patterns of psychotropic medication use among individuals with traumatic brain injury","volume":"37","author":"Albrecht","year":"2020","journal-title":"J Neurotrauma"},{"issue":"3","key":"2024082004113331400_R39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.neuropsych.21040104","article-title":"Treatment patterns of anxiety and posttraumatic stress disorder following traumatic brain injury","volume":"34","author":"Marks","year":"2022","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"2024082004113331400_R40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/jnnp-2020-324353","article-title":"Psychotropic and pain medication use in individuals with traumatic brain injury \u2013 A Swedish total population cohort study of 240,000 persons","volume":"92","author":"Molero","year":"2021","journal-title":"J Neurosurg Psychiatry"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/189\/Supplement_3\/323\/58855464\/usae120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/189\/Supplement_3\/323\/58855464\/usae120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T04:15:01Z","timestamp":1724127301000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/189\/Supplement_3\/323\/7735965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":40,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2024,8,19]]},"published-print":{"date-parts":[[2024,8,19]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usae120","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,19]]}}}